Skip to main content

Engineered resistance to camptothecin and antifolates by retroviral coexpression of tyrosyl DNA phosphodiesterase-I and thymidylate synthase

Cancer Chemotherapy and Pharmacology volume 53, pages 107–115 (2004)Cite this article

Abstract

Purpose

Gene transfer of cDNA sequences that confer drug resistance can be used (1) to protect hematopoietic cells against the toxic effects of chemotherapy, (2) for in vivo enrichment of genetically engineered cells and (3) to protect cytotoxic T lymphocytes in drug-resistant immunotherapy approaches for the treatment of cancer. We have previously developed strategies to confer resistance to agents targeting thymidylate synthase (TS) and have now expanded our drug resistance strategies to include retroviral expression of tyrosyl-DNA phosphodiesterase (TDP-I), an enzyme recently implicated in the repair of topoisomerase-I (Top-I)/DNA lesions induced by camptothecin (CPT). The combination of TS and Top-I inhibition has been shown to be an effective treatment for several types of cancer.

Materials and methods

Retroviral vectors were generated that individually encoded TS and TDP-I or that coexpressed both enzymes. Murine fibroblast and Chinese hamster lung transfectants were generated with the vectors and resistance to TS- and Top-I-directed inhibitors was tested. Murine bone marrow progenitor cells were also transduced using recombinant retroviruses encoding TS and TDP-I and the degree of drug resistance conferred to gene-modified cells was tested.

Results

Enforced expression of TDP-I increased TDP-I activity in gene-modified cells and conferred up to threefold resistance to CPT. The degree of resistance was dependent on the duration of drug treatment. Simultaneous expression of the TS gene encoding E. coli TS optimized for expression in mammalian cells (optecTS) and TDP-I conferred extremely high-level resistance to concurrent treatment with the TS-inhibitor BW1843U89 and CPT. Furthermore, by direct analysis of DNA fragmentation using the comet assay, substantial protection was conferred (fourfold) against DNA fragmentation associated with combination drug treatments by dual enzyme expression compared to non-modified cells. Hematopoietic progenitor assays of murine bone marrow cells transduced with retroviral vectors encoding TS and TDP-I showed that bone marrow cells could be protected from the cytotoxic effects of TS and Top-I inhibition.

Conclusions

Enforced expression of optecTS and TDP-I conferred antifolate and CPT resistance to genetically modified cells. Additionally, this work further illustrated a role for TDP-I in the repair of dead-end Top-I complexes and implied that TDP-I expression analysis may aid in predicting the therapeutic effectiveness of the CPT class of compounds.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

Fig. 1A, B
Fig. 2A, B
Fig. 3A, B
Fig. 4A, B
Fig. 5A–C
Fig. 6A–C
Fig. 7

References

  • Allay JA, Galipeau J, Blakley RL, Sorrentino BP (1998) In vivo selection of retrovirally transduced hematopoietic cells. Nat Med 4:1136

    Article  CAS  PubMed  Google Scholar 

  • Backus HH, Pinedo HM, Wouters D, Kuiper CM, Jansen G, van Groeningen CJ, Peters GJ (2000) Differences in the induction of DNA damage, cell cycle arrest, and cell death by 5-fluorouracil and antifolates. Oncol Res 12:231

    CAS  PubMed  Google Scholar 

  • Carreras CW, Santi DV (1995) The catalytic mechanism and structure of thymidylate synthase. Annu Rev Biochem 64:721

    Google Scholar 

  • Champoux JJ (2001) DNA topoisomerases: structure, function, and mechanism. Annu Rev Biochem 70:369

    Google Scholar 

  • Chen AY, Liu LF (1994) DNA topoisomerases: essential enzymes and lethal targets. Annu Rev Pharmacol Toxicol 34:191

    Article  CAS  PubMed  Google Scholar 

  • Davis BM, Koc ON, Gerson SL (2000) Limiting numbers of G156A O(6)-methylguanine-DNA methyltransferase-transduced marrow progenitors repopulate nonmyeloablated mice after drug selection. Blood 95:3078

    CAS  PubMed  Google Scholar 

  • Fairbairn DW, Olive PL, O’Neill KL (1995) The comet assay: a comprehensive review. Mutat Res 339:37

    PubMed  Google Scholar 

  • Fantz CR, Shaw D, Moore JG, Spencer HT (1998) Retroviral coexpression of thymidylate synthase and dihydrofolate reductase confers fluoropyrimidine and antifolate resistance. Biochem Biophys Res Commun 243:6

    Article  CAS  PubMed  Google Scholar 

  • Froelich-Ammon SJ, Osheroff N (1995) Topoisomerase poisons: harnessing the dark side of enzyme mechanism. J Biol Chem 270:21429

    Article  CAS  PubMed  Google Scholar 

  • Galipeau J, Li H, Paquin A, Sicilia F, Karpati G, Nalbantoglu J (1999) Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer. Cancer Res 59:2384

    CAS  PubMed  Google Scholar 

  • Hsiang YH, Lihou MG, Liu LF (1989a) Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Cancer Res 49:5077

    CAS  PubMed  Google Scholar 

  • Hsiang YH, Liu LF, Wall ME, Wani MC, Nicholas AW, Manikumar G, Kirschenbaum S, Silber R, Potmesil M (1989b) DNA topoisomerase I-mediated DNA cleavage and cytotoxicity of camptothecin analogues. Cancer Res 49:4385

    CAS  PubMed  Google Scholar 

  • Interthal H, Pouliot JJ, Champoux JJ (2001) The tyrosyl-DNA phosphodiesterase Tdp1 is a member of the phospholipase D superfamily. Proc Natl Acad Sci U S A 98:12009

    Article  CAS  PubMed  Google Scholar 

  • Knab AM, Fertala J, Bjornsti MA (1993) Mechanisms of camptothecin resistance in yeast DNA topoisomerase I mutants. J Biol Chem 268:22322

    CAS  PubMed  Google Scholar 

  • Koc ON, Allay JA, Lee K, Davis BM, Reese JS, Gerson SL (1996) Transfer of drug resistance genes into hematopoietic progenitors to improve chemotherapy tolerance. Semin Oncol 23:46

    CAS  Google Scholar 

  • Lansiaux A, Facompre M, Wattez N, Hildebrand MP, Bal C, Demarquay D, Lavergne O, Bigg DC, Bailly C (2001) Apoptosis induced by the homocamptothecin anticancer drug BN80915 in HL-60 cells. Mol Pharmacol 60:450

    CAS  PubMed  Google Scholar 

  • Lanza A, Tornaletti S, Rodolfo C, Scanavini MC, Pedrini AM (1996) Human DNA topoisomerase I-mediated cleavages stimulated by ultraviolet light-induced DNA damage. J Biol Chem 271:6978

    Article  CAS  PubMed  Google Scholar 

  • Licht T, Goldenberg SK, Vieira WD, Gottesman MM, Pastan I (2000) Drug selection of MDR1-transduced hematopoietic cells ex vivo increases transgene expression and chemoresistance in reconstituted bone marrow in mice. Gene Ther 4:348

    Article  Google Scholar 

  • McCarthy PJ, Sweetman SF, McKenna PG, McKelvey-Martin VJ (1997) Evaluation of manual and image analysis quantification of DNA damage in the alkaline comet assay. Mutagenesis 12:209

    CAS  PubMed  Google Scholar 

  • Nitiss JL, Wang JC (1996) Mechanisms of cell killing by drugs that trap covalent complexes between DNA topoisomerases and DNA. Mol Pharmacol 50:1095

    CAS  PubMed  Google Scholar 

  • Pouliot JJ, Yao KC, Robertson CA, Nash HA (1999) Yeast gene for a Tyr-DNA phosphodiesterase that repairs topoisomerase I complexes. Science 286:552

    Article  CAS  PubMed  Google Scholar 

  • Pouliot JJ, Robertson CA, Nash HA (2001) Pathways for repair of topoisomerase I covalent complexes in Saccharomyces cerevisiae. Genes Cells 6:677

    Article  CAS  PubMed  Google Scholar 

  • Pourquier P, Pommier Y (2001) Topoisomerase I-mediated DNA damage. Adv Cancer Res 80:189

    CAS  PubMed  Google Scholar 

  • Roffler SR, Chan J, Yeh MY (1994) Potentiation of radioimmunotherapy by inhibition of topoisomerase I. Cancer Res 54:1276

    CAS  PubMed  Google Scholar 

  • Shaw D, Berger FG, Spencer HT (2001) Retroviral expression of Escherichia coli thymidylate synthase cDNA confers high-level antifolate resistance to hematopoietic cells. Hum Gene Ther 12:51

    Article  CAS  PubMed  Google Scholar 

  • Sorrentino BP (2002) Gene therapy to protect haematopoietic cells from cytotoxic cancer drugs. Nat Rev Cancer 2:431

    Article  CAS  PubMed  Google Scholar 

  • Spencer HT, Sleep SE, Rehg JE, Blakley RL, Sorrentino BP (1996) A gene transfer strategy for making bone marrow cells resistant to trimetrexate. Blood 87:2579

    CAS  PubMed  Google Scholar 

  • Spencer HT, Villafranca JE, Appleman JR (1997) Kinetic scheme for thymidylate synthase from Escherichia coli: determination from measurements of ligand binding, primary and secondary isotope effects, and pre-steady state catalysis. Biochemistry 36:4212

    Article  CAS  PubMed  Google Scholar 

  • Wu J, Yin MB, Hapke G, Toth K, Rustum YM (2002) Induction of biphasic DNA double strand breaks and activation of multiple repair protein complexes by DNA topoisomerase I drug 7-ethyl-10-hydroxy-camptothecin. Mol Pharmacol 61:742

    Article  CAS  Google Scholar 

  • Yang SW, Burgin AB Jr, Huizenga BN, Robertson CA, Yao KC, Nash HA (1996) A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I topoisomerases. Proc Natl Acad Sci U S A 93:11534

    Article  CAS  PubMed  Google Scholar 

  • Ychou M, Raoul JL, Desseigne F, Borel C, Caroli-Bosc FX, Jacob JH, Seitz JF, Kramar A, Hua A, Lefebvre P, Couteau C, Merrouche Y (2002) High-dose, single-agent irinotecan as first-line therapy in the treatment of metastatic colorectal cancer. Cancer Chemother Pharmacol 50:383

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Affiliations

  1. Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC 29208, USA

    Takita Felder, Amanda H. Galloway & Maria Marjorette O. Pena

  2. Laboratory of Molecular Biology, National Institute of Mental Health, Building 36, Room 1B08, Bethesda, MD 20892-4034, USA

    Jeffery J. Pouliot

  3. Department of Pediatrics, Division of Hematology/Oncology and Bone Marrow Transplantation, Emory University School of Medicine, 2040 Ridgewood Dr. N.E., Atlanta, GA 30322, USA

    Michael C. Nivens & H. Trent Spencer

Authors
  1. Michael C. Nivens
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takita Felder
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Amanda H. Galloway
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maria Marjorette O. Pena
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jeffery J. Pouliot
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H. Trent Spencer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. Trent Spencer.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Nivens, M.C., Felder, T., Galloway, A.H. et al. Engineered resistance to camptothecin and antifolates by retroviral coexpression of tyrosyl DNA phosphodiesterase-I and thymidylate synthase. Cancer Chemother Pharmacol 53, 107–115 (2004). https://doi.org/10.1007/s00280-003-0717-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00280-003-0717-6

Keywords

  • Camptothecin
  • Antifolates
  • Drug resistance
  • Thymidylate synthase
  • Tyrosyl DNA phosphodiesterase